SWAlexander
Senior Member
- Messages
- 2,273
The International Declaration signed by leading experts in the field of ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) and Long COVID calls for a global collaborative effort to substantially expand biomedical research and drastically advance the development of curative treatments. The declaration was announced on 12 May at the International ME/CFS Conference 2025 in Berlin by Prof Carmen Scheibenbogen (Charité – Universitätsmedizin Berlin). The declaration has since garnered growing international support and has been signed by 65 international scientists and medical experts (as of 1 September 2025).
The Declaration recognises the growing public health crisis posed by ME/CFS and Long COVID and underlines the urgent need to advance biomedical research and drug development efforts globally. Highlighting the moral, medical, societal and scientific imperative to increase research efforts to uncover the disease mechanisms underlying ME/CFS and Long COVID, it calls on governments and international bodies to prioritise research funding on both diseases. The signatories explicitly outline the need for more clinical trials and translational studies to investigate potential treatment options, including repurposed drugs. They also call on pharmaceutical and biotechnology companies to be more actively engaged and incentivised to invest in research and drug development.
The Declaration also mentions the need for the research community to engage in active partnerships with patient communities, incorporating lived experience into study design, outcome measures, and the delivery of medical care. Furthermore, it calls upon medical education systems to reflect the current knowledge of ME/CFS and Long COVID in their curricula, empowering health care professionals to provide up-to-date medical care to patients.
More at: https://declaration.mecfs-research.org/en/declaration
The Declaration recognises the growing public health crisis posed by ME/CFS and Long COVID and underlines the urgent need to advance biomedical research and drug development efforts globally. Highlighting the moral, medical, societal and scientific imperative to increase research efforts to uncover the disease mechanisms underlying ME/CFS and Long COVID, it calls on governments and international bodies to prioritise research funding on both diseases. The signatories explicitly outline the need for more clinical trials and translational studies to investigate potential treatment options, including repurposed drugs. They also call on pharmaceutical and biotechnology companies to be more actively engaged and incentivised to invest in research and drug development.
The Declaration also mentions the need for the research community to engage in active partnerships with patient communities, incorporating lived experience into study design, outcome measures, and the delivery of medical care. Furthermore, it calls upon medical education systems to reflect the current knowledge of ME/CFS and Long COVID in their curricula, empowering health care professionals to provide up-to-date medical care to patients.
More at: https://declaration.mecfs-research.org/en/declaration